Please login to the form below
payer
This page shows the latest payer news and features for those working in and with pharma, biotech and healthcare.
Awesome abstraction
She wanted to know how to adapt the commercial operating model of her firm to the changing conditions of the market, especially the changing roles of payers and prescribers.
Latest news
-
Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
facilitate reimbursement by payers.
-
Prime Global launches new market access consultancy
The new consultancy will build on Prime Global’s existing capabilities, with the aim to deliver solutions for the payer industry. ... The science that is developing rapidly in areas such as oncology and rare diseases, presents new challenges in
-
Novartis faces criticism over Zolgensma ‘health lottery’
That posed a problem to payers and patients alike, with many criticising the price for making the innovative treatment almost impossible to access.
-
Pharma Brand Planners' Blog (Part 8)
Step 2: Collate your inputs to your forecast – current assumptions, current forecast, what will change, new research, new patient, payer or physician insights.
-
The digital shift in pharma marketing
New insights were sought as physicians started to work toward better health outcomes in light of regulatory pressures and payer demands.
More from news
Approximately 5 fully matching, plus 577 partially matching documents found.
Latest Intelligence
-
Great expectations: the urgent need for common purpose in Alzheimer’s disease
Long-term sustainability. Deals must be win-win because it is important to create a true long-term partnership between payers and industry. ... Payers must positively want to use new treatments and industry must feel its investment is rewarded.
-
Measuring what matters: how to create the right KPIs for your brand, launch and portfolio
The pharmaceutical industry is continuing its ‘disruption phase’ and therefore measurement of patient/physician/payer attitudes, engagement, behaviour as well as other activity, investment and competitive performance measures are more important
-
New strategic blueprint: the new first questions
Discussions on price and value quickly move from boardroom to conference room where they are disclosed earlier and earlier to payer partners. ... In the year ahead, more companies will create cross clinical-commercial teams to focus on building stronger
-
A market-adapted agile approach to launch excellence
relevance. 2. Less white space product differentiation. In crowded disease areas where compounds may show only incremental benefit, payers often make cross-product comparisons, differentiating and restricting treatment access.
-
It started with a miss
Companies can sometimes become so focused on the data and the science that they forget to think about what matters to the doctor, the patient or the payer. ... Definitions of value will obviously differ from customer to customer – payers, patients,
More from intelligence
Approximately 5 fully matching, plus 231 partially matching documents found.
Latest appointments
-
Christie Anbar appointed global healthcare lead at Ruder Finn
organisations and payer and hospital systems.
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
They also have additional experience of the challenges in an evolving payer environment, gained in prior roles in the NHS, the pharma industry and market access consulting.
-
Open Access Consulting appoints new director
In this role, Hurrell oversaw the team’s market access communications offering, supporting clients in the development of value communications materials with the payer as the ultimate end audience, including core ... value dossiers, payer-focused
-
Claes Buxfeldt joins NDA
He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
-
Acumen appoints new strategy director
policy makers, patient representatives, media, regulators and payers.
More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest from PMHub
-
Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
It’s now easier, faster and more convenient than ever to get the clinical or payer insight you need.
-
Using TRAVELLESS™ to provide tailored pharmaceutical training
teams, for strategic workshops or payer advisory boards, please contact us at discover@validinsight.com.
-
Ashfield to host webinar on Patient Support Programmes on Tuesday 10 October
Patients, payers and healthcare professionals have high expectations for patient support programmes (PSPs).
-
OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds
Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers.
-
The benefits of a expert-led market access strategy
Creating a market access strategy requires an understanding of what is in the head of the various stakeholders – the payers, physicians and patients organisations – and a knowledge of the drivers behind
More from PMHub
Approximately 13 fully matching, plus 132 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Imperial College London to lead major coronavirus home testing programme
- ViiV takes on Gilead’s PReP dominance with HIV injectable data
- Moderna’s coronavirus vaccine hits first objectives
- Roche says antibody test for COVID-19 should be ready in May
- AZ secures capacity for one billion coronavirus vaccine doses
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- AZ secures capacity for one billion coronavirus vaccine doses
- EMA starts review of MorphoSys’ tafasitamab for lymphoma
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Roche makes protein degradation play with $135m Vividion deal
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK government expands coronavirus testing criteria
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
- Ben Speller shares his thoughts on the value of disease specific congresses...
- OPEN Health use PR to support clinical trial recruitment
- International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
- Covid-19: what could it mean for the diabetic population?
- Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...
Quick links
Infographics
